Analytical validation of microdialysis analyzer for monitoring glucose, lactate and pyruvate in cerebral microdialysates

Clinica Chimica Acta

Volumn 412, Issue 7-8, 2011, Pages 647-654

  Tholance, Yannick ^a   Barcelos, Gleicy ^b,c   Quadrio, Isabelle ^a   Renaud, Bernard ^a   Dailler, Frederic ^d   Perret Liaudet, Armand ^a  

^a HCL   (France)

^b Cluse Roseraie   (France)

^c CNRS   (France)

^d HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Analytical validation; Brain injury; Cerebral microdialysis; Glucose; Lactate pyruvate ratio

Indexed keywords

GLUCOSE; LACTIC ACID; PYRUVIC ACID;

ACCURACY; ANALYZER; ARTICLE; CONTROLLED STUDY; DIALYSATE LEVEL; HUMAN; INTERMETHOD COMPARISON; MICRODIALYSIS; NEUROMONITORING; PRIORITY JOURNAL; PRODUCT RECOVERY; QUANTITATIVE ANALYSIS; SUBARACHNOID HEMORRHAGE;

BRAIN; GLUCOSE; HUMANS; LACTIC ACID; LIMIT OF DETECTION; MICRODIALYSIS; PYRUVIC ACID; REPRODUCIBILITY OF RESULTS;

EID: 79551474675     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.12.025     Document Type: Article

References (40)

1. Tossman U., Ungerstedt U. Microdialysis in the study of extracellular levels of amino acids in the rat brain. Acta Physiol Scand 1986, 128:9-14.
2. Ungerstedt U. Microdialysis-principles and applications for studies in animals and man. J Intern Med 1991, 230:365-373.
3. Hillered L., Persson L., Ponten U., Ungerstedt U. Neurometabolic monitoring of the ischaemic human brain using microdialysis. Acta Neurochir (Wien) 1990, 102:91-97.
4. Cantais E., Boret H., Carre E., Pernod G. Clinical use of bedside cerebral microdialysis: a review. Ann Fr Anesth Rèanim 2006, 25:20-28.
5. Skjoth-Rasmussen J., Schulz M., Kristensen S.R., Bjerre P. Delayed neurological deficits detected by an ischemic pattern in the extracellular cerebral metabolites in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 2004, 100:8-15.
6. Nilsson O.G., Brandt L., Ungerstedt U., Saveland H. Bedside detection of brain ischemia using intracerebral microdialysis: subarachnoid hemorrhage and delayed ischemic deterioration. Neurosurgery 1999, 45:1176-1184.
7. Persson L., Valtysson J., Enblad P., et al. Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg 1996, 84:606-616.
8. Sarrafzadeh A., Haux D., Sakowitz O., et al. Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis. Stroke 2003, 34:1382-1388.
9. Sarrafzadeh A.S., Haux D., Ludemann L., et al. Cerebral ischemia in aneurysmal subarachnoid hemorrhage: a correlative microdialysis-PET study. Stroke 2004, 35:638-643.
10. Samuelsson C., Howells T., Kumlien E., Enblad P., Hillered L., Ronne-Engstrom E. Relationship between intracranial hemodynamics and microdialysis markers of energy metabolism and glutamate-glutamine turnover in patients with subarachnoid hemorrhage. Clinical article. J Neurosurg 2009, 111:910-915.
11. Nordstrom C.H., Reinstrup P., Xu W., Gardenfors A., Ungerstedt U. Assessment of the lower limit for cerebral perfusion pressure in severe head injuries by bedside monitoring of regional energy metabolism. Anesthesiology 2003, 98:809-814.
12. Hutchinson P.J., Gupta A.K., Fryer T.F., et al. Correlation between cerebral blood flow, substrate delivery, and metabolism in head injury: a combined microdialysis and triple oxygen positron emission tomography study. J Cereb Blood Flow Metab 2002, 22:735-745.
13. Berger C., Schabitz W.R., Georgiadis D., Steiner T., Aschoff A., Schwab S. Effects of hypothermia on excitatory amino acids and metabolism in stroke patients: a microdialysis study. Stroke 2002, 33:519-524.
14. Dohmen C., Bosche B., Graf R., et al. Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke 2003, 34:2152-2158.
15. Samuelsson C., Hillered L., Enblad P., Ronne-Engstrom E. Microdialysis patterns in subarachnoid hemorrhage patients with focus on ischemic events and brain interstitial glutamine levels. Acta Neurochir (Wien) 2009, 151:437-446.
16. Ooie T., Terasaki T., Suzuki H., Sugiyama Y. Quantitative brain microdialysis study on the mechanism of quinolones distribution in the central nervous system. Drug Metab Dispos 1997; 25:784-789.
17. Young R.J., Lipman J., Gin T., Gomersall C.D., Joynt G.M., Oh T.E. Intermittent bolus dosing of ceftazidime in critically ill patients. J Antimicrob Chemother 1997, 40:269-273.
18. Chiu L.M., Menhinick A.M., Johnson P.W., Amsden G.W. Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers. J Antimicrob Chemother 2002, 50:1075-1079.
19. Bartal C., Danon A., Schlaeffer F., et al. Pharmacokinetic dosing of aminoglycosides: a controlled trial. Am J Med 2003, 114:194-198.
20. Treib J., Baron J.F. Hydroxethyl starch: effects on hemostasis. Ann Fr Anesth Rèanim 1998, 17:72-81.
21. Sakka S.G., Glauner A.K., Bulitta J.B., et al. Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial. Antimicrob Agents Chemother 2007, 51:3304-3310.
22. Uges J.W., van Huizen M.D., Engelsman J., et al. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus. Epilepsia 2009, 50:415-421.
23. Gaohua L., Maekawa T., Kimura H. An integrated model of thermodynamic-hemodynamic-pharmacokinetic system and its application on decoupling control of intracranial temperature and pressure in brain hypothermia treatment. J Theor Biol 2006, 242:16-31.
24. Li K., Zhang X., Yuan Y.S., Zhao F.L. A high-performance liquid chromatographic method for the determination of nicardipine in plasma and its application to pharmacokinetics in humans. Biomed Chromatogr 1998, 12:326-329.
25. Russo H., Bressolle F. Pharmacodynamics and pharmacokinetics of thiopental. Clin Pharmacokinet 1998, 35:95-134.
26. Yamamoto M., Kuzuya T., Baba H., Yamada K., Nabeshima T. Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type. J Clin Pharm Ther 2009, 34:473-483.
27. Vinge E., Andersson K.E., Brandt L., Ljunggren B., Nilsson L.G., Rosendal-Helgesen S. Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage. Eur J Clin Pharmacol 1986, 30:421-425.
28. Broglin D. Status epilepticus: pharmacokinetic basis of anticonvulsant treatment in adults. Ann Fr Anesth Rèanim 2001, 20:159-170.
29. Cloyd J.C., Lalonde R.L., Beniak T.E., Novack G.D. A single-blind, crossover comparison of the pharmacokinetics and cognitive effects of a new diazepam rectal gel with intravenous diazepam. Epilepsia 1998, 39:520-526.
30. Fraser C.G. Biological variation: from principles to practice 2001, AACC Press, Washington, DC.
31. Fraser C.G., Harris E.K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989, 27:409-437.
32. Nelson D.W., Bellander B.M., Maccallum R.M., et al. Cerebral microdialysis of patients with severe traumatic brain injury exhibits highly individualistic patterns as visualized by cluster analysis with self-organizing maps. Crit Care Med 2004, 32:2428-2436.
33. Unterberg A.W., Sakowitz O.W., Sarrafzadeh A.S., Benndorf G., Lanksch W.R. Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2001, 94:740-749.
34. Reinstrup P., Stahl N., Mellergard P., Uski T., Ungerstedt U., Nordstrom C.H. Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery 2000, 47:701-709.
35. Schulz M.K., Wang L.P., Tange M., Bjerre P. Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 2000, 93:808-814.
36. Westgard J.O. A method evaluation decision chart (MEDx chart) for judging method performance. Clin Lab Sci 1995, 8:277-283.
37. Vassault A., Grafmeyer D., de Graeve J., Cohen R., Beaudonnet A., Bienvenu J. Quality specifications and allowable standards for validation of methods used in clinical biochemistry. Ann Biol Clin (Paris) 1999, 57:685-695.
38. Ricos C., Alvarez V., Cava F., et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Investig 1999, 59:491-500.
39. Clinical Laboratory Improvement Act program fee collection-HCFA. Final rule with comment. Federal register 1992; 57:7188-7218.
40. Panteghini M., Pagani F. Biological variation of lactate and pyruvate in blood. Clin Chem 1993, 39:908.